Mussel mucin oral ulcer patch

Abstract

The utility model provides a mussel mucin oral ulcer patch, which belongs to the technical field of oral ulcer patches and comprises a circular patch, a circle of fixing layer is arranged on the outermost periphery of the patch, a circle of administration layer is arranged on the inner circle of the fixing layer, mussel mucin is contained on the administration layer, a slow release layer is arranged on the inner circle of the administration layer, and a sticking layer is arranged in the middle of the back of the patch. The utility model solves the problems that the product is easy to fall off due to various factors such as high activity intensity of the oral cavity part, humid environment, uneven part and the like, the long-time accurate administration cannot be realized, the operation is difficult in the use process, and the placement is inconvenient.

Description

Technical Field

[0001] The utility model belongs to the technical field of oral ulcer patches, and in particular relates to a mussel mucin oral ulcer patch. Background Art

[0002] Oral ulcer is a common clinical disease, which is prone to occur in the inner side of the lip, tongue, tongue belly, buccal mucosa, vestibule groove, soft palate and other parts. The pain is severe during the attack, and the local burning pain is obvious. In severe cases, it will also affect eating and speaking, causing great inconvenience to daily life. Topical medications or topical patches are commonly used treatments, but due to various factors such as frequent activities in the oral area, large range of motion, humid environment, uneven parts, etc., existing products are easy to fall off, cannot be accurately administered for a long time, and are difficult to operate and inconvenient to place during use. Therefore, there is a need for a sustained-release oral ulcer patch that can exert long-term effects and is easy to use. Utility Model Content

[0003] To achieve the above-mentioned purpose, the utility model provides a mussel mucin oral ulcer patch, comprising a circular patch, wherein the outermost portion of the patch is provided with a circle of fixing layer, the inner circle of the fixing layer is provided with a circle of drug administration layer, the drug administration layer contains mussel mucin, the inner circle of the drug administration layer is provided with a sustained-release layer, and the middle part of the back side of the patch is provided with an adhesive layer.

[0004] Furthermore, the diameter of the adhesive layer is smaller than the diameter of the drug administration layer.

[0005] Furthermore, the sustained-release layer is composed of gauze with different pore sizes.

[0006] The advantages of the utility model are as follows: the utility model solves the problems that the product is easy to fall off and cannot be accurately administered for a long time due to various factors such as high activity intensity in the oral area, humid environment, uneven area, etc., and is difficult to operate and place during use.

[0007] The utility model is described in detail below with reference to the accompanying drawings and embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0008] Figure 1 It is a front structural schematic diagram of the utility model.

[0009] Figure 2 It is a schematic diagram of the back structure of the utility model.

[0010] Figure 3 It is a vertical cross-sectional view of the utility model.

[0011] Explanation of the accompanying drawings: 1. patch; 2. fixing layer; 3. drug administration layer; 4. sustained-release layer; 5. adhesive layer. DETAILED DESCRIPTION

[0012] In order to further explain the technical means and effects adopted by the present invention to achieve the predetermined purpose, the specific implementation methods, structural features and effects of the present invention are described in detail below in conjunction with the accompanying drawings and embodiments.

[0013] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments of the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0014] In the description of the present invention, it should be understood that the terms "center", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "aligned", "overlap", "bottom", "inside", "outside", etc., indicating orientations or positional relationships, are based on the orientations or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as a limitation on the present invention.

[0015] The terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features; in the description of the present utility model, unless otherwise specified, "plurality" means two or more.

[0016] Example 1

[0017] This embodiment provides Figure 1 to Figure 3 A mussel mucin oral ulcer patch shown includes a circular patch 1, the outermost portion of the patch 1 is provided with a circle of fixing layer 2, the inner circle of the fixing layer 2 is provided with a circle of drug administration layer 3, the drug administration layer 3 contains mussel mucin, which is used to increase the efficacy of the drug, anti-inflammatory and promote wound healing, and cooperates with the fixing layer 2 to increase the adhesion of the patch 1 and achieve a stronger water-proof adhesion effect; the inner circle of the drug administration layer 3 is provided with a sustained-release layer 4, which is used to continuously release the main component and continuously act on the drug administration site, and an adhesive layer 5 is provided in the middle of the back side of the patch 1, on which a thin layer of adhesive material is attached, which can be connected to an adhesive rod, so that the patch can be conveniently transported to the oral cavity and accurately adhered and fixed to the site of action, which is not only convenient to use, but also can avoid contact between the patch 1 and the hand, and prevent contamination of the oral cavity, and the diameter of the adhesive layer 5 is smaller than the diameter of the drug administration layer 3.

[0018] When in use, first tear off the outer coat wrapping the patch 1, take out the patch 1 to be used, and then stick and fix it together with the adhesive layer 5 on the back of the patch 1 through the adhesive stick, and then control the adhesive stick by hand to align the drug delivery layer 3 of the patch 1 with the oral ulcer, and then fix the patch 1 in the oral cavity through the fixing layer 2, wherein the sustained-release layer 4 is composed of gauze with different apertures, and the mussel mucin particles are in the sieves with different apertures. Some of the mussel mucin particles first act on the ulcer surface through the large-aperture gauze, and then continue to pass through the gauze with different apertures and gradually reach the drug delivery site to achieve long-term effect.

[0019] Mussel mucin (MAP) is a protein extracted from natural mussels or obtained through genetic engineering, fermentation purification, etc. This protein can adsorb some cells related to wound healing to the vicinity of the wound through electrostatic force, accelerating wound healing; in addition, mussel mucin can also promote cell adhesion, etc. As a protective film, mussel mucin products can form a transparent, breathable, waterproof, and elastic protective film after being fixed to the surface of the material through DOPA. This film can protect the wound or surgical incision from water, bacteria, microorganisms, etc. Therefore, based on the characteristics of mussel mucin's adhesion and protective effect on the wound surface, a mouth ulcer patch product was designed with mussel mucin as the main ingredient.

[0020] In summary, the utility model solves the problems of easy falling off of the product, inability to accurately administer medicine for a long time, and difficulty in operation and placement during use due to various factors such as high activity intensity in the oral area, humid environment, and uneven area.

[0021] The above contents are further detailed descriptions of the present invention in combination with specific preferred implementations, and the specific implementation of the present invention cannot be considered to be limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as falling within the protection scope of the present invention.

Claims

1. A mussel mucin oral ulcer patch, characterized in that: The invention comprises a circular patch (1), wherein the outermost part of the patch (1) is provided with a circle of fixing layer (2), the inner circle of the fixing layer (2) is provided with a circle of drug administration layer (3), the drug administration layer (3) contains mussel mucin, the inner circle of the drug administration layer (3) is provided with a sustained-release layer (4), and the middle part of the back side of the patch (1) is provided with an adhesive layer (5).

2. A mussel mucin oral ulcer patch as claimed in claim 1, characterized in that: The diameter of the adhesive layer (5) is smaller than the diameter of the drug administration layer (3).

3. A mussel mucin oral ulcer patch as claimed in claim 1, characterized in that: The sustained-release layer (4) is composed of gauze with different pore sizes.

Images